A carregar...
Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis
Ibrutinib therapy was associated with an increased risk of bleeding in previous trials. In this systematic review and meta-analysis of published trials including patients treated with ibrutinib, the relative risk (95% confidence interval [CI]) of overall bleeding was significantly higher in ibrutini...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728050/ https://ncbi.nlm.nih.gov/pubmed/29296721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016001883 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|